Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

A randomized phase 1 study of testosterone replacement for patients with low-risk castration-resistant prostate cancer.

Szmulewitz R, Mohile S, Posadas E, Kunnavakkam R, Karrison T, Manchen E, Stadler WM. A randomized phase 1 study of testosterone replacement for patients with low-risk castration-resistant prostate cancer. Eur Urol. 2009 Jul; 56(1):97-103.

View in: PubMed